PharmAthene Reports Third Quarter 2016 Financial and Operational Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Grand Canyon Education places CFO on leave amid stock trade probe
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Funds sell $44bn in semiconductors on AI concerns
- RUM Group signs $13.7 billion GPU services deal, issues warrants
PharmAthene (PIP) Reports Q3 EPS of $1.67
November 4, 2016 4:06 PM EDTPharmAthene (NYSE: PIP) reported Q3 EPS of $1.67, versus ($0.02) reported last year. Revenue for the quarter came in at $993 thousand, versus $1.16 million reported last year.
For earnings history and earnings-related data on PharmAthene (PIP) click here.
... More